How does dopamine dysfunction link ADHD and addiction risk?

PostedNovember 25, 2025

UpdatedNovember 26, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Dopamine, the brain’s key chemical for motivation and reward, sits at the centre of both ADHD and addiction. According to NHS clinical reviews, people with ADHD often have disrupted dopamine signalling, which affects attention, impulse control, and emotional balance. This same dopamine dysregulation helps explain why individuals with ADHD are at higher risk of developing addictive behaviours.

The dopamine connection

Dopamine helps the brain weigh effort against reward. In ADHD, reduced dopamine activity in regions controlling motivation and inhibition means that everyday tasks can feel unrewarding, prompting the brain to seek stronger stimulation. Neuroscience research confirms that dopamine transporter (DAT) and D2/D3 receptor abnormalities are seen in both ADHD and substance use disorders. This makes natural rewards (like work or social praise) less satisfying, while drugs or alcohol can feel disproportionately reinforcing (Frontiers in Psychiatry, 2024).

Functional MRI studies and genetic research have found shared changes in motivation–reward and impulse-control networks, confirming that dopamine dysfunction underlies both ADHD symptoms and addiction risk (Nature Molecular Psychiatry, 2022).

Clinical guidance and treatment implications

According to NICE NG87, dopamine system dysfunction explains why impulsivity, emotional dysregulation, and risk-taking are so common in ADHD, and why integrated care is essential for those with co-occurring addiction.

Stimulant medications like methylphenidate and lisdexamfetamine work by blocking dopamine reuptake, helping normalise levels without creating the euphoric “high” associated with misuse. Evidence from BMJ research (2025) shows these treatments actually reduce the risk of addiction, suicide, and criminality, when properly prescribed and monitored.

For individuals at higher risk of substance misuse, the Royal College of Psychiatrists recommends non-stimulant medications and therapy-based interventions. NICE and NHS guidelines both emphasise that understanding dopamine’s role helps clinicians tailor safe, effective, and person-centred care.

The big picture

Dopamine imbalance creates a “reward gap”; everyday life feels under-stimulating, driving people to seek relief through substances. Treating ADHD early, with evidence-based medication and behavioural support, helps restore dopamine balance and lowers the risk of addiction in adulthood.

Takeaway

Dopamine dysfunction explains much of the overlap between ADHD and addiction. By recognising this shared brain chemistry and treating ADHD effectively, clinicians can reduce relapse risk and help individuals find balance without relying on substances.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.